Cresp 500mcg Injection is a medication used to stimulate the production of red blood cells. Its active ingredient is Darbepoetin alfa, a type of erythropoiesis-stimulating agent (ESA). Darbepoetin alfa works by mimicking the action of the natural hormone erythropoietin, which signals the bone marrow to produce more red blood cells. This is particularly beneficial for individuals suffering from anemia, a condition characterized by a deficiency of red blood cells or hemoglobin, leading to reduced oxygen transport throughout the body. Cresp 500mcg Injection is indicated for the treatment of anemia associated with chronic kidney disease (CKD) in both dialysis-dependent and non-dialysis-dependent patients, as well as for anemia in patients with cancer receiving chemotherapy.
The typical dosage of Cresp 500mcg Injection is determined by a healthcare professional based on the patient’s individual condition, hemoglobin levels, and response to treatment. It is administered via subcutaneous or intravenous injection. Common side effects may include headache, nausea, vomiting, diarrhea, and injection site reactions. More serious side effects, such as hypertension, blood clots, and allergic reactions, can occur and require immediate medical attention. Cresp 500mcg Injection should be stored at a temperature between 2°C and 8°C (36°F and 46°F) and protected from light. Do not freeze.
